Literature DB >> 24582094

Type 2 diabetes mellitus and hypertension: an update.

Guido Lastra1, Sofia Syed2, L Romayne Kurukulasuriya3, Camila Manrique1, James R Sowers4.   

Abstract

Patients with hypertension and type 2 diabetes are at increased risk of cardiovascular and chronic renal disease. Factors involved in the pathogenesis of both hypertension and type 2 diabetes include inappropriate activation of the renin-angiotensin-aldosterone system, oxidative stress, inflammation, impaired insulin-mediated vasodilatation, augmented sympathetic nervous system activation, altered innate and adaptive immunity, and abnormal sodium processing by the kidney. The renin-angiotensin-aldosterone system blockade is a key therapeutic strategy in the treatment of hypertension in type 2 diabetes. Emerging therapies for resistant hypertension as often exists in patients with diabetes, include renal denervation and carotid body denervation.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Chronic kidney disease; Diabetes; Hypertension; Renin-angiotensin-aldosterone system; Sympathetic nervous system

Mesh:

Year:  2013        PMID: 24582094      PMCID: PMC3942662          DOI: 10.1016/j.ecl.2013.09.005

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  122 in total

1.  50th anniversary of aldosterone.

Authors:  Jonathan S Williams; Gordon H Williams
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

Review 2.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

Review 3.  Aldosterone and vascular inflammation.

Authors:  Nancy J Brown
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

4.  Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I.

Authors:  N R Cook; S K Kumanyika; J A Cutler
Journal:  Am J Epidemiol       Date:  1998-09-01       Impact factor: 4.897

5.  Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial).

Authors:  Josep Redon; Giuseppe Mancia; Peter Sleight; Helmut Schumacher; Peggy Gao; Janice Pogue; Robert Fagard; Paolo Verdecchia; Michael Weber; Michael Böhm; Bryan Williams; Khalid Yusoff; Koon Teo; Salim Yusuf
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

7.  Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis.

Authors:  April P Carson; George Howard; Gregory L Burke; Steven Shea; Emily B Levitan; Paul Muntner
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

8.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

9.  A novel adipokine CTRP1 stimulates aldosterone production.

Authors:  Jun Ho Jeon; Kun-yong Kim; Jae Hyeong Kim; Ahmi Baek; Hyungin Cho; Young Ho Lee; Jong Wan Kim; Dohee Kim; Seung Hyun Han; Jong-Seok Lim; Keun Il Kim; Do Young Yoon; Soo-Hyun Kim; Goo Taeg Oh; Eunjoon Kim; Young Yang
Journal:  FASEB J       Date:  2008-01-02       Impact factor: 5.191

10.  Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults.

Authors:  A R Dyer; K Liu; M Walsh; C Kiefe; D R Jacobs; D E Bild
Journal:  J Hum Hypertens       Date:  1999-01       Impact factor: 3.012

View more
  80 in total

1.  Type 2 Diabetes, Change in Depressive Symptoms Over Time, and Cerebral Small Vessel Disease: Longitudinal Data of the AGES-Reykjavik Study.

Authors:  Sytze P Rensma; Thomas T van Sloten; Jennifer Ding; Sigurdur Sigurdsson; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer
Journal:  Diabetes Care       Date:  2020-06-11       Impact factor: 19.112

Review 2.  PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.

Authors:  Rania Nasrallah; Ramzi Hassouneh; Richard L Hébert
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

3.  Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.

Authors:  Joshua J Joseph; Justin B Echouffo-Tcheugui; Rita R Kalyani; Hsin-Chieh Yeh; Alain G Bertoni; Valery S Effoe; Ramon Casanova; Mario Sims; Adolfo Correa; Wen-Chih Wu; Gary S Wand; Sherita H Golden
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 4.  Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.

Authors:  Yukako Tatsumi; Takayoshi Ohkubo
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

Review 5.  Autophagy: a housekeeper in cardiorenal metabolic health and disease.

Authors:  Guanghong Jia; James R Sowers
Journal:  Biochim Biophys Acta       Date:  2014-06-28

6.  Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.

Authors:  Styliani Goulopoulou; Johanna L Hannan; Takayuki Matsumoto; Safia Ogbi; Adviye Ergul; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-08       Impact factor: 4.733

7.  Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.

Authors:  Eugene Sobngwi; Liliane Mfeukeu-Kuate; Merveille Kouam; Aurel T Tankeu; Chris N Nganou-Gnindjio; Ba Hamadou; Martine Etoa; Eliane Ngassam; Ariane Nkamgna; Mesmin Y Dehayem; François F Kaze; Andre P Kengne; Jean C Mbanya
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-08       Impact factor: 3.738

8.  Zinc deficiency induces hypertension by promoting renal Na+ reabsorption.

Authors:  Clintoria R Williams; Monisha Mistry; Aswathy M Cheriyan; Jasmine M Williams; Meagan K Naraine; Carla L Ellis; Rickta Mallick; Abinash C Mistry; Jennifer L Gooch; Benjamin Ko; Hui Cai; Robert S Hoover
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

9.  Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women.

Authors:  Xiaojing Yuan; Huikun Liu; Leishen Wang; Shuang Zhang; Cuiping Zhang; Junhong Leng; Ling Dong; Li Lv; Fengjun Lv; Huiguang Tian; Lu Qi; Jaakko Tuomilehto; Gang Hu
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

Review 10.  Diabetes and Cardiovascular Disease: an Update.

Authors:  Rajaa Almourani; Bhavana Chinnakotla; Richa Patel; L Romayne Kurukulasuriya; James Sowers
Journal:  Curr Diab Rep       Date:  2019-12-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.